Commonwealth Biotechnologies, GL Biochem (Shanghai) deal

Discovery and development services company Commonwealth will acquire peptide supply company GL Biochem in a stock deal. GL Group shareholders will own 68-80% of Commonwealth's share capital on a fully-diluted basis after the deal. Commonwealth said it expects the deal to be accretive to its earnings. ...